id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-280361-242yq90p	Emmanuel, Stip	Psychiatric adverse events with hydrochloroquine during COVID-19 Pandemic	2020-06-20		.txt	text/plain	1110	34	22	Active clinical trials were Chloroquine and hydroxychloroquine for the prevention or treatment of Novel Coronavirus Disease (COVID-19) in Africa: caution for inappropriate off-label use in healthcare settings Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and metaanalysis Chloroquine for the 2019 novel coronavirus Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection Neuropsychiatric adverse events of chloroquine: A real-world pharmacovigilance study using the FAERS database Malaria control strategies in French armed forces Use of antiviral drugs to reduce COVID-19 transmission An Outbreak of Malaria in US Army Rangers Returning From Afghanistan Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Issues relevant to mental health promotion in frontline health care providers managing quarantined/isolated COVID19 patients Psychosis following chloroquine ingestion: a 10-year comparative study from a malaria-hyperendemic district of India Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus-a case report Chloroquine psychosis Chloroquine psychosis masquerading as PCP: a case report Transient global amnesia following ingestion of chloroquine Psychosis likely induced by hydropxychloroquine in a patient with chronic Q fever: a case report and clinically relevant review of pharmacology Antimalarial psychosis revisited Toxic psychosis due to chloroquine Psychiatric symptoms induced by hydroxychloroquine Behavorial toxicity and equivocal suicide associated with chloroquine and its derivatives Hydroxychloroquine-induced acute psychosis in a systemic lupus erythematosus female Suicide by skull stab wounds: a case of drug-induced psychosis Chloroquine-associated psychosis mimicking very late-onset schizophrenia: case report Manic episode Lovestone S. Chloroquine-induced mania Psychose aiguë après prise de chloroquine Prolonged neuropsychiatric effects following management of chloroquine intoxication with psychotropic polypharmacy Chloroquine psychosis: a chemical psychosis? Toxic psychosis during chloroquine treatment Two cases of chloroquine psychosis Psychotic symptoms in volunteers serving overseas Insomnia Lupus Reis J. Insomnia induced by chloroquine in the treatment of lupus erythematosus disseminatus Psychiatric complications with chloroquine and quinacrine Chloroquine-induced recurrent psychosis Toxic psychosis due to quinacrine and chloroquine Serious psychiatric symptoms after chloroquine treatment following experimental malaria infection Chloroquine seizures Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report Toxic psychosis : a complication of antimalarial therapy key: cord-280361-242yq90p authors: Emmanuel, Stip; Ostlundh, Linda title: Psychiatric adverse events with hydrochloroquine during COVID-19 Pandemic date: 2020-06-20 journal: Asian J Psychiatr DOI: 10.1016/	cache/cord-280361-242yq90p.txt	txt/cord-280361-242yq90p.txt
